BNR

Burning Rock Biotech Ltd ADR

13.42

Nov 06 • 3:59 PM ET +0.17 (1.28%)

13.42

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Healthcare Diagnostics & Research China Micro NASD

Peers: GH GRAL NEO PSNL FLGT NTRA MYGN CSTL BDSX TEM

| Held by: BAIV

Scroll to Statements

Index	-
Market Cap	117.96M
Enterprise Value	62.84M
Income	-9.74M
Sales	71.59M
Book/sh	6.96
Cash/sh	7.03
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	667
IPO	Jun 12, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	1.65
P/B	1.93
P/C	1.91
P/FCF	-
EV/EBITDA	-
EV/Sales	0.88
Quick Ratio	2.87
Current Ratio	3.03
Debt/Eq	0.09
LT Debt/Eq	0.05
Option/Short	No / Yes

EPS (ttm)	-0.91
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	62.63% 40.80%
Sales past 3/5Y	-3.55% 3.80%
EPS Y/Y TTM	51.30%
Sales Y/Y TTM	-3.65%
EPS Q/Q	-99.84%
Sales Q/Q	-3.60%
Earnings	Sep 10 BMO
EPS/Sales Surpr.	- -

Insider Own	0.24%
Insider Trans	-
Inst Own	19.81%
Inst Trans	-1.15%
ROA	-8.63%
ROE	-12.81%
ROIC	-12.69%
Gross Margin	74.52%
Oper. Margin	-13.02%
Profit Margin	-13.60%
SMA20	5.52%
SMA50	-0.21%
SMA200	-16.13%
Trades

Shs Outstand	8.79M
Shs Float	8.76M
Short Float	0.42%
Short Ratio	1.07
Short Interest	0.04M
52W High	41.72 -67.83%
52W Low	6.79 97.64%
Volatility	12.08% 12.84%
ATR (14)	1.58
RSI (14)	52.57
Beta	1.43
Rel Volume	0.39
Avg Volume	34.47K
Volume	13,546

Perf Week	23.12%
Perf Month	-11.71%
Perf Quarter	23.61%
Perf Half Y	-19.93%
Perf YTD	-33.40%
Perf Year	9.55%
Perf 3Y	32.87%
Perf 5Y	-90.88%
Perf 10Y	-
Recom	-
Target Price	31.65
Prev Close	13.25
Price	13.42
Change %	1.28%

Avg. Price Target

$31.65

Implied Upside

+135.8%

Analysts1incl. previous ratings

Rating Distribution1 Buy · 0 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Oct 15, 2021	Resumed	CCowen	Outperform
Jul 07, 2020	Initiated	CCowen	Outperform

Sep-10-26 07:17AM	Burning Rock Reports Second Quarter 2026 Financial Results (GlobeNewswire)
Jul-02-26 07:19AM	Burning Rock Announces Founder's Purchase of Its ADSs (GlobeNewswire) +9.60%
Jun-09-26 06:38AM	Burning Rock Reports First Quarter 2026 Financial Results (GlobeNewswire) -9.81%
Apr-28-26 06:45AM	Burning Rock Publishes 2025 Annual Report on Form 20-F (GlobeNewswire) -12.64%
Apr-02-26 06:25AM	Burning Rock Announces Founder's Purchase of Its ADSs (GlobeNewswire)
07:08AM	Loading…
Mar-12-26 07:08AM	Burning Rock Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Jan-05-26 01:16AM	Burning Rock Announces Founder's Purchase of Its ADSs (GlobeNewswire) +24.39%
Dec-22-25 11:04PM	Burning Rock Announces Results of 2025 Annual General Meeting (GlobeNewswire) +7.79% -6.93%
Dec-01-25 04:11AM	Burning Rock Announces 2025 Annual General Meeting to be Held on December 23, 2025 (GlobeNewswire) -12.04%
Nov-26-25 11:10AM	This Undiscovered Biotech Stock Has Quintupled in a Year and Just Hit New Highs (Barchart) +9.72%
Nov-20-25 01:52AM	Burning Rock Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Sep-24-25 02:42AM	Burning Rock's OncoGuide OncoScreen Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer (GlobeNewswire)
Sep-08-25 01:39AM	Burning Rock Reports Second Quarter 2025 Financial Results (GlobeNewswire) +9.16%
Jun-06-25 03:31AM	Burning Rock Reports First Quarter 2025 Financial Results (GlobeNewswire)
Mar-25-25 07:45AM	Burning Rock Reports Unaudited Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire) -12.36%
04:56AM	Loading…
Dec-31-24 04:56AM	Burning Rock Announces Results of 2024 Annual General Meeting (GlobeNewswire)
Dec-05-24 06:29AM	Burning Rock Biotechs Strategic Growth and Financial Results (TipRanks)
Dec-03-24 11:59PM	Burning Rock Reports Third Quarter 2024 Financial Results (GlobeNewswire) +13.67%
06:45AM	Burning Rock Announces 2024 Annual General Meeting to be Held on December 31, 2024 (GlobeNewswire)
Oct-10-24 11:16PM	NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China (GlobeNewswire)
Sep-27-24 08:37AM	Burning Rock Announces Changes to Management and Board of Directors (GlobeNewswire)
Aug-22-24 11:59PM	Burning Rock Reports Second Quarter 2024 Financial Results (GlobeNewswire) -6.76%
Aug-19-24 02:21AM	Burning Rock Biotech Limited Announces Expected Delisting of American Depositary Shares (GlobeNewswire)
Jun-03-24 12:41AM	Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement (GlobeNewswire)
May-30-24 08:02AM	Burning Rock Biotech Limited (NASDAQ:BNR) Q1 2024 Earnings Call Transcript (Insider Monkey) -5.30%
03:42AM	Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines (GlobeNewswire)
May-29-24 11:20PM	Q1 2024 Burning Rock Biotech Ltd Earnings Call (Thomson Reuters StreetEvents)
09:52AM	BNR Stock Earnings: Burning Rock Biotech Reported Results for Q1 2024 (InvestorPlace)
01:34AM	Burning Rock Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-23-24 02:00AM	Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024 (GlobeNewswire)
02:02AM	Loading…
May-14-24 02:02AM	Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024 (GlobeNewswire)
Apr-29-24 03:30AM	Burning Rock Publishes 2023 Annual Report on Form 20-F (GlobeNewswire)
Apr-26-24 01:59AM	Burning Rock Announces ADS Ratio Change (GlobeNewswire)
Mar-30-24 12:39AM	Q4 2023 Burning Rock Biotech Ltd Earnings Call (Thomson Reuters StreetEvents)
Mar-28-24 10:52PM	BNR Stock Earnings: Burning Rock Biotech Reported Results for Q4 2023 (InvestorPlace)
05:16PM	Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Jan-04-24 01:03AM	Burning Rock Announces Receipt of Notification from NASDAQ (GlobeNewswire)
Dec-19-23 09:35PM	Burning Rock Announces Results of 2023 Annual General Meeting (GlobeNewswire)
Dec-01-23 08:39AM	Burning Rock Biotech Limited (NASDAQ:BNR) Q3 2023 Earnings Call Transcript (Insider Monkey)
02:21AM	Q3 2023 Burning Rock Biotech Ltd Earnings Call (Thomson Reuters StreetEvents)
Nov-30-23 01:25AM	Burning Rock Reports Third Quarter 2023 Financial Results (GlobeNewswire) -7.31%
Nov-22-23 02:04AM	Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023 (GlobeNewswire)
Nov-20-23 08:55PM	Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023 (GlobeNewswire)
Oct-30-23 03:20AM	Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics (GlobeNewswire) -5.21%
Oct-15-23 07:18PM	Burning Rock Received Breakthrough Device Designation from China's NMPA for its Multi-Cancer Early Detection Test (GlobeNewswire)
Sep-07-23 10:43PM	Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer Cell (GlobeNewswire) -8.94%
Sep-01-23 08:46AM	Burning Rock Biotech Limited (NASDAQ:BNR) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-31-23 09:03PM	Q2 2023 Burning Rock Biotech Ltd Earnings Call (Thomson Reuters StreetEvents)
01:30AM	Burning Rock Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-04-23 03:27AM	Burning Rock Provides Second Quarter 2023 Business Updates and Schedules Earnings Release on August 31, 2023 (GlobeNewswire)
Jun-28-23 04:05AM	Burning Rock Announces Resignation and Appointment of Directors (GlobeNewswire)
Jun-09-23 01:47PM	A Look At The Fair Value Of Burning Rock Biotech Limited (NASDAQ:BNR) (Simply Wall St.)
Jun-08-23 12:20AM	Burning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment, with results published in the New England Journal of Medicine (GlobeNewswire)
May-31-23 12:53PM	Burning Rock Biotech Limited (NASDAQ:BNR) Q1 2023 Earnings Call Transcript (Insider Monkey)
04:36AM	Q1 2023 Burning Rock Biotech Ltd Earnings Call (Thomson Reuters StreetEvents)
May-30-23 09:40AM	Is Burning Rock Biotech (BNR) Outperforming Other Business Services Stocks This Year? (Zacks)
12:53AM	Burning Rock Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-24-23 08:42AM	While institutions own 25% of Burning Rock Biotech Limited (NASDAQ:BNR), private equity firms are its largest shareholders with 26% ownership (Simply Wall St.)
Apr-27-23 01:01AM	Burning Rock Provides First Quarter 2023 Business Updates and Schedules Earnings Release on May 30, 2023 (GlobeNewswire) +7.48%
Apr-20-23 10:43PM	Burning Rock Publishes 2022 Annual Report on Form 20-F (GlobeNewswire)
Apr-17-23 09:59AM	Burning Rock Biotech Limited's (NASDAQ:BNR) Share Price Is Matching Sentiment Around Its Revenues (Simply Wall St.)
Mar-30-23 08:28AM	Burning Rock Biotech Limited (NASDAQ:BNR) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-28-23 02:08AM	Burning Rock Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire) +5.43%
Mar-19-23 08:47AM	Is Burning Rock Biotech (NASDAQ:BNR) In A Good Position To Deliver On Growth Plans? (Simply Wall St.)
Mar-14-23 09:44AM	Apollo Global to Buy Univar in $8.1 Billion Deal Including Debt (The Wall Street Journal) +6.07%
Mar-07-23 03:38AM	Burning Rock Schedules Fourth Quarter and Full Year 2022 Earnings Release on March 28, 2023 (GlobeNewswire)
Jan-17-23 08:37PM	Burning Rock provides an update on 2022 revenue guidance (GlobeNewswire)
Jan-16-23 08:36AM	Even after rising 28% this past week, Burning Rock Biotech (NASDAQ:BNR) shareholders are still down 63% over the past year (Simply Wall St.)
Jan-03-23 09:25AM	Burning Rock Received FDA Breakthrough Device Designation for its OverC Multi-Cancer Detection Blood Test (GlobeNewswire)
Dec-27-22 09:10AM	Burning Rock Biotech Limited (NASDAQ:BNR) Q3 2022 Earnings Call Transcript (Insider Monkey)
Dec-15-22 06:52AM	Burning Rock Biotech Limited (NASDAQ:BNR) has caught the attention of institutional investors who hold a sizeable 26% stake (Simply Wall St.)
Nov-21-22 12:00PM	Burning Rock Biotech Limited Sponsored ADR (BNR) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Nov-15-22 09:20PM	Burning Rock Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-10-22 05:15AM	Burning Rock Biotech Second Quarter 2022 Earnings: Misses Expectations (Simply Wall St.)
Nov-01-22 06:10AM	Admission to Trading on the London Stock Exchange (GlobeNewswire) -7.77%
Oct-27-22 07:50AM	Burning Rock Announces Publication of Prospectus in connection with Direct Listing on the London Stock Exchange (GlobeNewswire)
Oct-25-22 12:46AM	Burning Rock Provides Third Quarter 2022 Business Updates and Schedules Earnings Release on November 16, 2022 (GlobeNewswire)
Oct-21-22 01:01PM	Burning Rock Announces Publication of Registration Document and Potential Direct Listing on the London Stock Exchange (GlobeNewswire)
Oct-10-22 06:25AM	We Think Burning Rock Biotech (NASDAQ:BNR) Needs To Drive Business Growth Carefully (Simply Wall St.)
Sep-08-22 04:56AM	Burning Rock Announces Results of 2022 Annual General Meeting (GlobeNewswire)
Aug-31-22 04:30PM	Burning Rock Biotech Limited (BNR) Q2 2022 Earnings Call Transcript (Motley Fool) +20.62% -12.50%
01:24PM	Why Shares of Alibaba, JD.com, and Burning Rock Biotech Are Rising Today (Motley Fool)
07:05AM	Burning Rock Biotech Limited Sponsored ADR (BNR) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:29AM	Burning Rock Reports Second Quarter 2022 Financial Results (GlobeNewswire)
Aug-09-22 07:46AM	Burning Rock Biotech (NASDAQ:BNR) shareholders have endured a 84% loss from investing in the stock a year ago (Simply Wall St.)
Aug-04-22 09:10AM	Burning Rock Provides Second Quarter 2022 Business Updates and Schedules Earnings Release on August 31, 2022 (GlobeNewswire) +5.02%
Aug-03-22 02:12AM	Burning Rock Announces 2022 Annual General Meeting to be Held on September 8, 2022 (GlobeNewswire)
Jul-14-22 09:50PM	Burning Rock Announces Resignation of Director (GlobeNewswire)
Jul-08-22 06:49AM	What Is The Ownership Structure Like For Burning Rock Biotech Limited (NASDAQ:BNR)? (Simply Wall St.)
Jun-30-22 10:57AM	Burning Rock Announces the Launch of Chinas First Prospective Interventional Validation Study on Multi-Cancer Early Detection - the PREVENT Study (GlobeNewswire) +8.18%
Jun-24-22 03:26AM	Burning Rock Announces Changes to Board Composition (GlobeNewswire)
Jun-21-22 02:03AM	Burning Rock Announces US$10 Million Share Repurchase Program (GlobeNewswire) +8.63%
01:59AM	Burning Rock Announces Plan to Pursue An Alternative Listing (GlobeNewswire)
Jun-15-22 08:01AM	Burning Rock Presents Latest Clinical Data from THUNDER Study at 2022 ASCO Annual Meeting (PR Newswire) +13.11%
Jun-01-22 07:49AM	Burning Rock Receives CE Mark for its OverC Multi-Cancer Detection Blood Test Kit (PR Newswire)
May-31-22 01:30PM	Burning Rock Biotech Limited (BNR) Q1 2022 Earnings Call Transcript (Motley Fool)
02:32AM	Burning Rock Reports First Quarter 2022 Financial Results (GlobeNewswire)
May-16-22 04:00AM	Burning Rock Schedules First Quarter of 2022 Earnings Release on May 31, 2022 (GlobeNewswire)
May-05-22 06:45PM	Opendoor Technologies Inc. (OPEN) Surpasses Q1 Earnings and Revenue Estimates (Zacks) -7.40% -17.15%
May-02-22 11:43AM	Is Burning Rock Biotech (NASDAQ:BNR) In A Good Position To Invest In Growth? (Simply Wall St.) +6.35%

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Han Yusheng	Director	Jun 24 '26	Buy	8.00	250,000	2,000,000	18,379,186	Jul 02 08:30 AM
Han Yusheng	Director	Jun 12 '26	Buy	9.25	210,000	1,942,143	17,907,436	Jul 02 08:30 AM
Han Yusheng	Director	Jun 16 '26	Buy	9.00	111,110	999,957	18,018,546	Jul 02 08:30 AM
Han Yusheng	Director	Jun 22 '26	Buy	7.45	104,650	779,674	18,123,196	Jul 02 08:30 AM
Han Yusheng	Director	Jun 11 '26	Buy	8.74	24,760	216,388	17,697,436	Jul 02 08:30 AM
Han Yusheng	Director	Jun 26 '26	Buy	8.00	24,900	199,090	18,404,086	Jul 02 08:30 AM
Han Yusheng	Director	Jun 23 '26	Buy	7.50	5,990	44,920	18,129,186	Jul 02 08:30 AM
Han Yusheng	Director	Mar 31 '26	Buy	17.36	314,870	5,466,143	17,672,676	Apr 02 07:17 AM

Burning Rock Biotech Ltd. engages in the investment of medical fields. It specializes in next-generation sequencing diagnostics solutions for precision medicine in oncology. The firm operates through the following segments: Central Laboratory Business, In-Hospital Business and Pharma Research and Development Services. Its products and clinical applications include companion diagnostics for targeted therapy and immunotherapy, benign, malignant tumor diagnosis, minimal residual disease monitoring, tumor recurrence and progression prediction and tumor susceptibility tests. The company was founded by Yu Sheng Han in January 2014 and is headquartered in Guangzhou, China.

FounderMr. Yusheng Han

Vice President of FinanceMs. Xiaozhi Hu

CTO & DirectorDr. Zhihong Zhang

Senior AdvisorMr. Hao Liu

Senior VP of Pharma Biomarker & CDx. Services and International Diagnostics DivisionDr. Xinru Mao

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BNR

Burning Rock Biotech Ltd ADR

Upgrade your Finviz experience